GSK Consumer Healthcare turns volatile after Q2 numbers

GlaxoSmithkline Consumer Healthcare lost 1.87% to Rs 4,600 at 14:26 IST on BSE after net profit rose 12.53% to Rs 119.96 crore on 18.02% growth in total income to Rs 928.33 crore in Q2 June 2013 over Q2 June 2012.

The Q2 result was announced during trading hours today, 1 August 2013.

Meanwhile, the S&P BSE Sensex was down 2.98 points or 0.02% at 19,342.72.

On BSE, 2,818 shares were traded in the counter as against average daily volume of 5,206 shares in the past one quarter.

The stock was volatile. The stock lost as much as 2.84% at the day's low of Rs 4,554.40 so far during the day. The stock rose as much as 3.14% at the day's high of Rs 4,835 so far during the day. The stock had hit a record high of Rs 6,020 on 31 May 2013. The stock had hit a 52-week low of Rs 2,621.55 on 31 July 2012.

The stock had underperformed the market over the past one month till 31 July 2013, sliding 8.79% compared with the Sensex's 0.26% fall. The scrip had, however, outperformed the market in past one quarter, jumping 16.83% as against Sensex's 0.81% fall.

The large-cap company has equity capital of Rs 42.06 crore. Face value per share is Rs 10.

GlaxoSmithkline Consumer Healthcare is a leading player in the malted food drinks segment. Its major brands include Horlicks, Boost, Viva and Maltova.

Powered by Capital Market - Live News